The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Open accessAbstract
Cellular senescence, which is characterized by an irreversible cell-cycle arrest 1 accompanied by a distinctive secretory phenotype 2, can be induced through various intracellular and extracellular factors. Senescent cells that express the cell cycle inhibitory protein p16 INK4A have been found to actively drive naturally occurring age-related tissue deterioration 3,4 and contribute to several diseases associated with ageing, including atherosclerosis 5 and osteoarthritis 6. Various markers of senescence have been observed in patients with neurodegenerative diseases 7-9; however, a role for senescent cells in the aetiology of these pathologies is unknown. Here we show a causal link between the accumulation of senescent cells and cognition-associated neuronal loss. We found that the MAPT P301S PS19 mouse model of tau-dependent neurodegenerative disease 10 accumulates p16 INK4A-positive senescent astrocytes and microglia. Clearance of these cells as they arise using INK-ATTAC transgenic mice prevents gliosis, hyperphosphorylation of both soluble and insoluble tau leading to neurofibrillary tangle deposition, and degeneration of cortical and hippocampal neurons, thus preserving cognitive function. Pharmacological intervention with a first-generation senolytic modulates tau aggregation. Collectively, these results show that senescent cells have a role in the initiation and progression of tau-mediated disease, and suggest that targeting senescent cells may provide a therapeutic avenue for the treatment of these pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence has been observed in neurons, astrocytes, microglia, oligodendrocytes, and oligodendrocyte progenitor cells (57–59).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, clearance of Sncs either genetically or pharmacologically in mice leads to functional improvements in models of neurodegenerative diseases such as PD and AD (57–59).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic clearance of senescent cells or senolytic treatment in tauopathy mouse models mitigated cognitive decline and neurode-generation158,159”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These two mouse models have greatly accelerated our understanding of whether senescent cells contribute to ageing and age-related diseases, at least in model organisms, for numerous diseases, including Parkinson disease196, Alzheimer disease197,198, atherosclerosis175, idiopathic pulmonary fibrosis199, chronic obstructive pulmonary disease200 and osteoarthritis201.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [197]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence contributes to Alzheimer’s disease (AD) pathogenesis.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, studies in preclinical models of various CNS disorders have demonstrated reduced gliosis and neuroinflammation with senescent cell clearance, for example,6,8,17,19,25,50.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence suggests a detrimental impact of senescent cells, including p16INK4A-positive senescent astrocytes and microglia, and Aβ plaque-associated Olig2- and NG2-expressing p16INK4A-positive oligodendrocyte progenitor cells (OPCs) in neuronal loss and cognitive impairment in mouse models of AD (Bussian et al., 2018; Zhang et al., 2019).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Bussian et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The involvement of senescence and SASP in MCI and AD is further strengthened by experimental evidence that senolytic therapy provides beneficial effects in accelerated aging, 106 tauopathy, 22 and AD mouse models 25 by reducing brain inflammation.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies demonstrated that tau aggregates can trigger cellular senescence and inflammation”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescent astrocytes and microglia accumulate in a tau‐dependent mouse model of AD where they contribute to cognitive decline in these mice (Bussian et al, 2018; Zhang et al, 2019).”
From The struggle of a good friend getting old: cellular senescence in viral responses and therapy (2021) · cites this paper as Bussian et al, 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preclinical studies using different models have suggested that senolytic treatments can reduce the abundance of senescent cells, disease-relevant pathology and cognitive deficits [8, 56, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the pharmacological and genetic elimination of senescent cells has shown therapeutic benefits for AD pathology in mouse models of tau and amyloid pathology [11, 83, 122].”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bussian et al. reported that clearance of p16+ senescent astrocytes and microglia using INKATTAC transgene restrains gliosis, super-phosphorylation of both soluble and insoluble tau resulting in neurofibrillary tangle deposition and degeneration of cortical and hippocampal neurons, thus restoring cognitive function.”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More recently, researchers have identified senescent‐like brain cells in murine models of AD and tauopathy, and their removal via senolytic drugs seems to mitigate pathology and improve cognition (Bussian et al, 2018; Musi et al, 2018; Zhang et al, 2019; Ogrodnik et al, 2021).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Bussian et al, 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescent cells accumulate with ageing and age-associated diseases, limiting lifespan and healthspan in mice11–16.”
From Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In aged organisms, senescent cells can contribute to a variety of age- related pathologies, including pulmonary fibrosis, biliary liver damage, arteriosclerosis, retinopathy, osteoarthritis, dementia and diabetes mellitus 13-19 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cells are implicated in sterile inflammation, wound healing, and age-related processes, including neurodegeneration”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Bussian et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous human and rodent model studies have highlighted the important role of astrocytes in AD and tau pathology, with astrocyte activation occurring prior to large scale NFT formation, synaptic dysfunction, and neuronal loss (Bussian et al., 2018; Shi et al., 2017; Yoshiyama et al., 2007).”
From Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia (2021) · cites this paper as Bussian et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which suggests that cellular senescence has a causative effect in this pathology”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other research teams confirmed the association between tau and senescence in PS19 tau transgenic mice8 and the effective clearance of senescent cells using D + Q in the Tg(APP/PS1) Aβ-producing mouse model19.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Increased numbers of p16-positive astrocytes and microglia also have been reported with tau-mediated disease initiation and progression in a mouse model [8].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Excessive senescent cells have been demonstrated to play a causal role in driving ageing [26] and chronic diseases [18] using genetic and pharmacologic approaches.”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Putative senescent states have been suggested in a variety of neural subpopulations with aging and in various disease contexts, including microglia [26–30], neurons [31–33], astrocytes [26,34,35], and oligodendrocyte progenitor cells [36].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Removal of the p16Ink4a-positive senescent cells, for instance, using a suicide gene under the regulation of the Cdkn2a promoter has been shown to attenuate progression of age-related decline and preserve cognitive function in both an accelerated aging AD mouse model and a tauopathy mouse model (Baker et al., 2011; Bussian et al., 2018).”
From Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2022) · cites this paper as Bussian et al., 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fibroblasts present not only papillary and reticular phenotypes, but also heterogeneous populations if studied at the single-cell level58,59.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Keratinocytes display different properties across different strata of the epidermis”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Keratinocytes and fibroblasts can be further divided into different subtypes.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“retrotransposon expression has in fact been shown to have a role in DNA damage (Yousefzadeh et al. 2021), cellular senescence (Bussian et al. 2018, De Cecco et al. 2019b, Li et al. 2013, Musi et al. 2018), and inflammatory signaling (Franceschi et al. 2018, Gulen et al. 2023), which are well-described features of both aging and some neurodegenerative disorders”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Bussian et al. 2018
Experimental — accuracy not yet measuredIn the citing paper
“The aggregation of misfolded proteins, including Aβ plaques and tau neurofibrillary tangles, may also promote neuronal and glial senescent phenotypes (171), as do other common facets of neurodegeneration, such as mitochondrial dysfunction and abnormal proteostasis (22, 172, 173).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [22]
In the citing paper
“These persisting senescent cells have been recently tied to multiple chronic diseases other than atherosclerosis, including diabetes mellitus,85 obesity,85 Alzheimer’s disease,86 heart failure,10,87 idiopathic pulmonary fibrosis,88,89 chronic obstructive pulmonary disease,90 chronic kidney disease,91 cancer,92 and osteoarthritis.93”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [86]
In the citing paper
“Senolytic elimination of Aβ-associated senescent OPCs or Tau pathology-associated senescent glial cells ameliorates cognitive impairment in different AD mouse models (Bussian et al., 2018; Zhang et al., 2019).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Bussian et al., 2018
In the citing paper
“Recent studies in humans and animal models demonstrate that aging is associated with increased accumulation of senescent cells.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
In the citing paper
“Various endogenous and exogenous stressors (eg, pathological tau aggregates) can induce senescence in different types of brain cells. 22 , 23 , 24 , 25”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
In the citing paper
“selective clearance of senescent cells extends the healthy lifespan in aged animals and also prevents AD‐associated brain pathology and cognitive decline, 22 , 23 , 24 , 25”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
In the citing paper
“eliminating senescent cells with senolytics reduces tau aggregation and inflammation and improves cognitive performance in vivo.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
In the citing paper
“Senolytic therapy has shown promising results in various animal models, including tauopathies.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [22]
In the citing paper
“CD38 is emerging as a key enzyme involved in inflammageing and senescence45,105,106, which are strongly associated with neurodegenerative diseases124,128,168,169.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [128]
In the citing paper
“Senotherapy has been shown to ameliorate phenotypes in all of these mouse models, attenuating tau phosphorylation and aggregation, 39 reducing neuroinflammation and amyloid β plague load, and improving cognitive deficits.40”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [39]
In the citing paper
“work establishing a role for senescence in the aging and diseased brain reveals DNA damage may play a central role in neuroinflammation associated with neurodegenerative disease.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Bussian et al, 2018
In the citing paper
“For example both microglia (Bussian et al, 2018), astrocytes (Bussian et al, 2018), and neurons (Musi et al, 2018) have been found to display senescent‐like phenotypes in Tau P301S mice, and have been proposed as drivers of cognitive decline and neurodegeneration.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Bussian et al, 2018
In the citing paper
“It has since been shown that removal of senescent cells in the brain mitigates neurofibrillary tangle (NFT) burden, amyloid burden, neuronal loss, and cognitive decline in mouse models of tauopathy (Bussian et al, 2018; Musi et al, 2018), AD (Zhang et al, 2019), PD (Chinta et al, 2018), and normal aging (Ogrodnik et al, 2021).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Bussian et al, 2018
In the citing paper
“genetic and pharmacological clearance of senescent cells confers therapeutic benefits in models of Alzheimer’s disease”
From Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions (2021) · cites this paper as Bussian et al., 2018
In the citing paper
“They have also been identified as a putative senescent population in natural aging in both humans [42] and mice [27], mouse models of AD pathology [26], and in TBI [28,29].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [26]
In the citing paper
“Regardless of the hypothesized identity of the senescent population, each of these studies demonstrated pathology mitigation following pharmacological removal of senescent cells [26,33,36].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [26]
In the citing paper
“Whole-body clearance of p16-expressing cells in a mouse model of tauopathy led to an amelioration of disease, with microglia identified as a senescent cell population in this disease model [26].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [26]
In the citing paper
“Nevertheless, some senolytics have been effectively used in mouse models of neurological disease to alleviate pathology including dasatinib and quercetin [36] and navitoclax [26], which has led to senolytic therapies entering clinical trials for the modulation of AD [171].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [26]
In the citing paper
“Senescent cells accumulate with age [23, 157, 175], neurodegenerative disease and cognitive decline [15], neuropsychiatric disorders [33], and have recently been discovered to accumulate after TBI [3, 123, 131, 132, 151].”
From Early onset senescence and cognitive impairment in a murine model of repeated mTBI (2021) · cites this paper as [15]
In the citing paper
“Similarly, accumulation of senescent glial cells drives tau pathology and cognitive decline in mice [14].”
From DNA repair deficiency and senescence in concussed professional athletes involved in contact sports (2019) · cites this paper as [14]
In the citing paper
“The role of senescent cells in cognitive decline and p-tau pathology has been demonstrated in a transgenic mouse model of AD, in which eliminating senescent cells through senolytic intervention resulted in reduced tau phosphorylation, improved cognitive outcomes, and the prevention of the upregulation of senescence genes [14].”
From DNA repair deficiency and senescence in concussed professional athletes involved in contact sports (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Self-citationAdult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
Ming, G.-L., & Song, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.001 · Cited by 2,651
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Jeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515
Self-citationSenescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,002
Neuwahl, J., Neumann, C. A., Fitz, A. C., Biermann, A. D., Magel, M., Friedrich, A., Sellin, L. K., Stork, B., Piekorz, R. P., Proksch, P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06755-x · Cited by 9
Chen, Z., Mao, Q., Zhang, J., Wu, Y., Shan, X., Geng, Y., Fan, J., Cai, Z., & Xiang, R. (2025) · Aging Cell · doi:10.1111/acel.14470 · Cited by 13
Functional abnormalities of the glymphatic system in cognitive disorders
Shentu, W., Kong, Q., Zhang, Y., Li, W., Chen, Q., Yan, S., Wang, J., Lai, Q., Qi, X., & Qiao, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01049 · Cited by 9
Radiation-Induced Brain Injury with Special Reference to Astrocytes as a Therapeutic Target.
Wang, C.-P., Fan, X.-J., Shi, Y.-W., & Tang, F.-R. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin25907 · Cited by 8
Shoubridge, A. P., Carpenter, L., Flynn, E. F., Papanicolas, L. E., Collins, J., Gordon, D., Lynn, D. J., Whitehead, C., Leong, L. E. X., Cations, M., et al. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf053 · Cited by 10
Polzer, O., Kinloch, E., & Fitzsimons, C. P. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100141 · Cited by 10
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102802 · Cited by 9
Microglial States Are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer's Disease
Li, B., Wang, S., Kerman, B. E., Hugo, C., Shwab, E. K., Shu, C., Chiba‐Falek, O., Arvanitakis, Z., & Yassine, H. N. (2025) · Aging Cell · doi:10.1111/acel.70189 · Cited by 12
Regulation of aging-related chronic diseases by dietary polyphenols: An updated overview
Liu, J., Dong, K., Deng, Q., Zou, Z., Chen, S., Feng, N., Wang, J., Huang, H., & Wu, Q. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101163 · Cited by 10
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13
Wu, Q., Klopack, E. T., Kim, J. K., Arpawong, T. E., Thyagarajan, B., Cole, S., Faul, J. D., Zhou, F., & Crimmins, E. M. (2025) · Nature Communications · doi:10.1038/s41467-025-64835-8 · Cited by 9
Bertoni, G., Ristori, S., & Monti, D. (2026) · Cells · doi:10.3390/cells15080657 · Cited by 10
Tau aggregation and its relation to selected forms of neuronal cell death.
Tolkovsky, A. M., & Spillantini, M. G. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.80530 · Cited by 9
Lyons, C. E., Graves, S. I., Razzoli, M., Jeganathan, K. B., Mansk, R. P., McGonigle, S., Sabarinathan, N., van Deursen, J. M., Baker, D. J., & Bartolomucci, A. (2023) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001256 · Cited by 9
Self-citationCellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
Chandrakar, L., Ambatwar, R., & Khatik, G. L. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266273698231107110956 · Cited by 10
Lu, M., Hao, C., Xu, L., Feng, Y., Jiang, J., Wang, Y., Xu, J., Kuang, H., Xu, C., & Sun, M. (2024) · Science China Chemistry · doi:10.1007/s11426-023-1859-4 · Cited by 9
Chiral Nanoprobes and Their Biological Effects
Sun, M., Li, S., Hao, C., Xu, C., & Kuang, H. (2020) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202000392 · Cited by 9
Ilyinsky, N. S., Nesterov, S. V., Shestoperova, E. I., Fonin, A. V., Uversky, V. N., & Gordeliy, V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921030056 · Cited by 9
Balog, M., Blažetić, S., Ivić, V., Labak, I., Krajnik, B., Marín, R., Canerina‐Amaro, A., Pereda, D., Bardak, A., Gáspár, R., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15256 · Cited by 8
Li, P., Wu, Q., Li, X., Hu, B., Wen, W., & Xu, S. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111400 · Cited by 9
A mini-review of the role of condensin in human nervous system diseases
Pang, D., Yu, S., & Yang, X. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.889796 · Cited by 9
An evaluation of the role of miR-361-5p in senescence and systemic ageing
Manni, E., Jeffery, N. M., Chambers, D., Slade, L., Etheridge, T., & Harries, L. W. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112127 · Cited by 9
Context-dependent transcriptional regulation of microglial proliferationPreprint
Belhocine, S., Xavier, A. M., Distéfano‐Gagné, F., Fiola, S., Rivest, S., & Gosselin, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.29.436988 · Cited by 9
Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration
Sharma, K., Sarkar, J., Trisal, A., Ghosh, R., Dixit, A., & Singh, A. K. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.016 · Cited by 8
Yang, F., Zhang, N., Ou, G., & Xu, S.-W. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.5 · Cited by 11
Network of extracellular vesicles surrounding senescent cells
Okawa, H., Tanaka, Y., & Takahashi, A. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109953 · Cited by 8
Dementia and metabolic syndrome: a bibliometric analysis
Peng, T., Yang, Y., Ma, J., Xu, P., Xie, X., Hu, N., & Yan, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400589 · Cited by 10
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Distinct factors drive the progression of tau pathology in Alzheimer’s disease
Luo, Y., Yu, H., & Ye, K. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.04.001 · Cited by 9
Niazi, S. K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123904 · Cited by 8
Kumar, M., Ray, S., & Sil, S. (2025) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.65 · Cited by 8
Park, B., Nicaise, A. M., Tsitsipatis, D., Pirvan, L., Žucha, D., Munteanu, A., Prasad, P., Larraz, M., Bulgaru, C., Kollyfas, R., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.022 · Cited by 12
Chloroquine, the Coronavirus Crisis, and Neurodegeneration: A Perspective
Pedrioli, G., Patani, R., & Paganetti, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.596528 · Cited by 8
Maurer, G. S., & Clayton, Z. S. (2022) · Future Cardiology · doi:10.2217/fca-2022-0086 · Cited by 10
Zhu, S., Shi, J., Jin, Q., Zhang, Y., Zhang, R., Chen, X., Wang, C., Shi, T., & Li, L. (2023) · Aging · doi:10.18632/aging.205087 · Cited by 8
Liu, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09162-1 · Cited by 8
Excess iron accumulation mediated senescence in diabetic kidney injury
Cheng, X., Li, Y., Chen, L., Jiang, C., Peng, S., Yao, P., & Tang, Y. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23683 · Cited by 9
Khan, T., Hussain, A. I., Casilli, T. P., Frayser, L. A., Cho, M., Williams, G., McFall, D. J., & Forcelli, P. A. (2024) · Aging Cell · doi:10.1111/acel.14239 · Cited by 9
Engineering Antibodies Targeting p16 MHC-Peptide Complexes
Rettko, N. J., Campisi, J., & Wells, J. A. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00808 · Cited by 8
Advances in biomarkers and diagnostic significance of organ aging
Chen, Y., Li, J., Liu, X., Geng, Z., Xu, K., & Su, J. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.03.009 · Cited by 9
SATB1 is a Dopaminergic Neuron‐Specific Regulator of Cellular Senescence
Cancio-Bello, A. M., & Sáez-Atiénzar, S. (2020) · Movement Disorders · doi:10.1002/mds.27978 · Cited by 8
Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9
Zhang, J., Xie, D., Jiao, D., Zhou, S. Y., Liu, S., Ju, Z., Hu, L., Li, Q., Yao, C., & Chen, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32688 · Cited by 9
Lu, J., Zhou, Q., Zhu, D., Song, H., Xie, G., Zhao, X., Huang, Y., Cao, P., Wang, J., & Shen, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.010 · Cited by 7
The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease
Torre, M., Zanella, C. A., & Feany, M. Β. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.013 · Cited by 8
Tau Pathology Drives Disease‐Associated Astrocyte Reactivity in Salt‐Induced Neurodegeneration
Rui, T., Huang, H., Zheng, K., Fan, H., Zhang, J., Guo, Z., Man, H., Brazhe, N. A., Semyanov, A. V., Lu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202410799 · Cited by 9
Garg, A., Saroj, J., Tiwari, S., Das, U., Shukla, N., Ghosh, J. K., & Bandyopadhyay, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510337 · Cited by 7
Horikawa, I., Yamada, L., Harris, B. T., & Harris, C. C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.031 · Cited by 7
Ebrahimi, R., Bordbar, S., Azad, G., Davoody, S., Mahmoudi, M., & Esmaeilpour, K. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08403-4 · Cited by 8
Cellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 9
Carvalho, D. B., Díaz‐Amarilla, P., Dapueto, R., Santi, M. D., Duarte, P., Savio, E., Engler, H., Abin‐Carriquiry, J. A., & Arredondo, F. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02105-2 · Cited by 7
Chen, Y., Shen, J., Zhao, X., He, Q., & Zhang, J. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12812 · Cited by 7
Elimination of senescent cells prevents neurodegeneration in mice
Penney, J., & Tsai, L. (2018) · Nature · doi:10.1038/d41586-018-06677-7 · Cited by 7
Profiling Microglia in a Mouse Model of Machado–Joseph Disease
Campos, A. B., Duarte‐Silva, S., Fernandes, B., das Neves, S. P., Marques, F., Teixeira‐Castro, A., Neves‐Carvalho, A., Monteiro‐Fernandes, D., Portugal, C. C., Socodato, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020237 · Cited by 7
YAP: a novel target for Alzheimer's disease
Xu, X., Wang, Y., & Huang, Z. (2022) · Aging · doi:10.18632/aging.204045 · Cited by 7
Nutrition Interventions of Herbal Compounds on Cellular Senescence
Chen, Z., Wu, Y., Lin, Q., Cai, J., Liu, X., & Liang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1059257 · Cited by 8
ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1–BLM Interaction
Cui, F., Han, X., Zhang, X., Wang, S., Liang, N., Tan, Q., Sha, W., & Li, J. (2022) · Cells · doi:10.3390/cells12010145 · Cited by 7
Getting Too Old Too Quickly for Their Job: Senescent Glial Cells Promote Neurodegeneration
Gosselin, D., & Rivest, S. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.006 · Cited by 7
Targeted Senolytic Strategies Based on the Senescent Surfaceome
Ekpenyong‐Akiba, A. E., Poblocka, M., & Macip, S. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_6 · Cited by 7
Wang, S., Li, B., Cai, Z., Hugo, C., Li, J., Sun, Y. E., Lü, Q., Remaley, A. T., Julia, T. C. W., Chui, H. C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4373201/v1 · Cited by 7
TREM2-dependent senescent microglia conserved in aging and Alzheimer’s disease
Rachmian, N., Medina, S., Cherqui, U., Akiva, H., Deitch, D., Edilbi, D., Croese, T., Salame, T., Peralta Ramos, J., Cahalon, L., et al. (2023) · doi:10.1101/2023.03.20.533401 · Cited by 6
de Gérando, A. M., Khasnavis, A., Welikovitch, L. A., Bhavsar, H., Glynn, C. A., Quittot, N., Perbet, R., & Hyman, B. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01849-1 · Cited by 6
Dual-target-activated dual-color molecular probe for imaging analysis of cellular senescence
Wang, L., Hong, D., Li, J., Wu, L., Xia, Y., Di, X., Wang, J., Xie, Y., Da, J., & Liu, Y. (2025) · Chemical Communications · doi:10.1039/d5cc00755k · Cited by 6
Jiang, F., Wang, N., & Meng, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360321 · Cited by 6
Chen, H., Sun, Y., Li, Q.-F., Du, Y.-T., Hu, N., Sui, A., Luo, X.-Q., Huang, X., Zhu, C., Yang, G., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq7665 · Cited by 7
Ristori, S., Bertoni, G., Bigi, A., Cecchi, C., Sollazzo, M., Iommarini, L., Monti, D., & Bientinesi, E. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112116 · Cited by 6
Unraveling the molecular mechanisms of aluminium chloride-induced Alzheimer’s disease
Paul, R., & Firdous, S. M. (2026) · BioMetals · doi:10.1007/s10534-026-00788-9 · Cited by 6
Xu, Q., Li, G., Zhang, H., Jiang, Z., Gao, X., Li, Z., Prata, L. G. P. L., Kirkland, J. L., Zhang, G., & Sun, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-70302-9 · Cited by 6
Pacca-Corrêa, J. B. L., Fernandes, B. M., Siqueira, M., Schafbenker, R., Baumart, G. J., Damico, I. V., Gomes, F. C. A., & Matias, I. C. P. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04709-7 · Cited by 6
Glial dynamics in brain aging: Cellular heterogeneity and regional vulnerability
Suk, K. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102915 · Cited by 6
A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain
Orr, M. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231462 · Cited by 6
Heneka, M. T. (2024) · Nature Immunology · doi:10.1038/s41590-024-01854-5 · Cited by 6
Shirai, T., Okazaki, S., Tanifuji, T., Numata, S., Nakayama, T., Yoshida, T., Mouri, K., Otsuka, I., Hiroi, N., & Hishimoto, A. (2024) · Schizophrenia · doi:10.1038/s41537-024-00531-8 · Cited by 6
Kloske, C. M., Mahinrad, S., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Butts, B., Carrillo, M. C., Chakrabarty, P., Chen, X., Craft, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14291 · Cited by 6
Xu, Y., Liu, S., Zhou, Z., Qin, H., Zhang, Y., Zhang, G., Ma, H., Han, X., Liu, H., & Liu, Z. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae189 · Cited by 6
Advances in pharmacological interventions of aging in mice
Qian, M., & Liu, B. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.11.002 · Cited by 6
The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6
Application potential of senolytics in clinical treatment
Li, T., Li, S., Ma, K., & Kong, J. (2023) · Biogerontology · doi:10.1007/s10522-023-10084-5 · Cited by 6
Horn, M. D., Forest, S. C., Saied, A. A., & MacLean, A. G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1368517 · Cited by 5
Emerging roles of senolytics/senomorphics in HIV-related co-morbidities
Kaur, G., Rahman, M. S., Shaikh, S. B., Panda, K., Chinnapaiyan, S., Estevez, M. S., Xia, L., Unwalla, H. J., & Rahman, I. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116179 · Cited by 6
He, Y., Zheng, G., & Zhou, D. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_1 · Cited by 6
Krüger-Fürhoff, I. M., Schmidt, N., & Vice, S. (2021) · De Gruyter eBooks · doi:10.1515/9783110713626 · Cited by 5
A Comprehensive Update of Cerebral Organoids between Applications and Challenges
Li, X., Shopit, A., & Wang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7264649 · Cited by 6
Sentinel p16 INK4a + cells in the basement membrane form a reparative niche in the lungPreprint
de Mochel, N. R., Cheong, K. N., Cassandras, M., Wang, C., Krasilnikov, M., Matatia, P. R., Molofsky, A. B., Campisi, J., & Peng, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.10.142893 · Cited by 6
Watson, M. A., Devrukhkar, P. R., Murad, N., Wu, F., Kim, M. J., Anvari, H., Tran, U., Martin, N. G., Tran, T., Zaza, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692228 · Cited by 7
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming
Zhang, W., Song, S., Zhang, Y., Pan, Y., Hu, D., & Wang, Y. (2026) · npj Aging · doi:10.1038/s41514-026-00355-z · Cited by 6
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
News from the old: Aging features in the intracardiac, musculoskeletal, and enteric nervous systems
Haider, S., Sassu, E., Stefanovska, D., Stoyek, M. R., Preißl, S., & Hortells, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102690 · Cited by 7
Wang, J., Liao, M., Tong, Z., Yuan, S., Hu, Z., Chen, Z., Zeng, F., Zou, R., Chen, D., Chen, G., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04853-1 · Cited by 5
Huang, H., Lu, W., Huang, Y., Su, Y., Luo, R., Zeng, Y., Yuan, C., Jia, Z., & Xuemin, W. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120586 · Cited by 6
Palomares, D., Vanparys, A., Jorgji, J., Paître, E., Kienlen‐Campard, P., & Suelves, N. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02118-5 · Cited by 7
Enomoto, S., Hur, Y. H., Solodova, T., Neumann, J., Cerione, R. A., & Antonyak, M. A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110821 · Cited by 5
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 6
Evolving insights into the identity and function of dark microglia
Flury, A. G., St‐Pierre, M., Ayata, P., & Tremblay, M. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.11.002 · Cited by 7
Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 6
Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders
Kempuraj, D., Babu, P. R. R., Jayakumar, N., Belur, M. G., Cohan, C. H., Sharma, A., Sanchez-Guerrero, E., Anderson, T., Kong, D., Chinnappan, B., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1756670 · Cited by 6
Ferreira, D., Chmiela, T., Eriksdotter, M., Jack, C. R., Kalpouzos, G., Marseglia, A., Mecocci, P., Nordberg, A. K., Religa, D., & Westman, E. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70096 · Cited by 7
Cantero‐Fortiz, Y., Butler, C., Montalbán, X., & Boada, M. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1805691 · Cited by 6
Persistent and transient senescent cells contribute to brain-barrier development
Watson, L. A., Adelsheim, Z., Carter, M. J., Carter, G. T., Jimenez-Reyes, K. L., Du, H., Zhu, Z., Berry, D. B., Paredez, M. C., Palaniappan, R. H., et al. (2026) · Cell · doi:10.1016/j.cell.2026.05.022 · Cited by 5
Rossi, G. R., Jensen, A., Ng, S., Yin, Z., Li, A., Misra, A., Hoff, D. D. V., Gruber, L., Gruber, M., & Han, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-44211-6 · Cited by 5
Metadata
- Authors
- Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- Venue
- Nature
- Published
- 2018-09-19
- Volume
- 562
- Issue
- 7728
- Pages
- 578-582
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6206507
- OpenAlex
- W2890865075
- Cited by
- 1,289
- References
- 35
- Citations by year
- 2026: 140 · 2025: 165 · 2024: 185 · 2023: 161 · 2022: 173 · 2021: 157 · 2020: 169 · 2019: 127 · 2018: 12
- FWCI
- 79.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (R01AG053229)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- cellular senescence, senolytics, astrocytes, microglia, tauopathy, neurofibrillary tangles, tau hyperphosphorylation, cognitive decline, neuronal loss, p16INK4a, gliosis, neurodegeneration
- MeSH terms
- Aniline Compounds, Animals, Astrocytes, Female, Gliosis, Humans, Male, Mice, Transgenic, Neuroglia, Phosphorylation, Solubility, Sulfonamides, Neurofibrillary Tangles, tau Proteins, Cellular Senescence, Transgenes, Cyclin-Dependent Kinase Inhibitor p16, Mice, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
